Treatment of solar lentigo using Q-switch laser

Phase 2

Recruiting

• Conditions: solar lentigo.; other melanin hyperpigmentation; L81.4

• Registration Number: IRCT20201216049734N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Patients with solar lentigo based on clinical diagnosis
Bilateral and symmetrical lesions

Exclusion Criteria

associated physical illness
treatment in the last 6 months
Existence of substance or alcohol in the last six months
Pregnancy or breastfeeding in women

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Degree of pigmentation. Timepoint: At the beginning of the study and the sixteenth week. Method of measurement: Clinical examination.;Pain. Timepoint: Fourth and eighth week. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Hyperpigmentation and hypo pigmentation. Timepoint: At the beginning of the study and the sixteenth wee. Method of measurement: clinical.